Basel Medical (BMGL) Cash & Equivalents (2024 - 2025)
Basel Medical's Cash & Equivalents history spans 2 years, with the latest figure at $2.3 million for Q2 2025.
- For Q2 2025, Cash & Equivalents rose 62.42% year-over-year to $2.3 million; the TTM value through Jun 2025 reached $2.3 million, up 62.42%, while the annual FY2025 figure was $2.3 million, 61.82% up from the prior year.
- Cash & Equivalents for Q2 2025 was $2.3 million at Basel Medical, up from $1.4 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $2.3 million in Q2 2025 and bottomed at $1.4 million in Q2 2024.